<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biochemistry</journal-id><journal-id journal-id-type="publisher-id">bi</journal-id><journal-id journal-id-type="coden">bichaw</journal-id><journal-title-group><journal-title>Biochemistry</journal-title></journal-title-group><issn pub-type="ppub">0006-2960</issn><issn pub-type="epub">1520-4995</issn><publisher><publisher-name>American Chemical Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1021/bi900437z</article-id><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title>Structure and Function of <italic>Bacillus subtilis</italic> YphP, a Prokaryotic Disulfide Isomerase with a CXC Catalytic Motif<xref rid="fs1" ref-type="fn">&#x02020;</xref><sup>,</sup><xref rid="ac1" ref-type="fn">&#x02021;</xref></article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Derewenda</surname><given-names>Urszula</given-names></name><xref rid="aff1" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Boczek</surname><given-names>Tomasz</given-names></name><xref rid="aff1" ref-type="aff">&#x000a7;</xref><xref rid="fn2" ref-type="author-notes">&#x025cb;</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Gorres</surname><given-names>Kelly L.</given-names></name><xref rid="aff2" ref-type="aff">&#x02225;</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>Yu</surname><given-names>Minmin</given-names></name></contrib><contrib contrib-type="author" id="ath5"><name><surname>Hung</surname><given-names>Li-wei</given-names></name><xref rid="aff3" ref-type="aff">#</xref><xref rid="aff4" ref-type="aff">&#x025b3;</xref></contrib><contrib contrib-type="author" id="ath6"><name><surname>Cooper</surname><given-names>David</given-names></name><xref rid="aff1" ref-type="aff">&#x000a7;</xref></contrib><contrib contrib-type="author" id="ath7"><name><surname>Joachimiak</surname><given-names>Andrzej</given-names></name><xref rid="aff5" ref-type="aff">&#x025c7;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath8"><name><surname>Raines</surname><given-names>Ronald T.</given-names></name><xref rid="cor1" ref-type="author-notes">*</xref><xref rid="aff2" ref-type="aff">&#x02225;</xref><xref rid="aff6" ref-type="aff">&#x022a5;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath9"><name><surname>Derewenda</surname><given-names>Zygmunt S.</given-names></name><xref rid="cor1" ref-type="author-notes">*</xref><xref rid="aff1" ref-type="aff">&#x000a7;</xref></contrib><aff id="aff1"><label>&#x000a7;</label>Department of Molecular Physiology and Biological Physics and the ISFI PSI2 Center, University of Virginia School of Medicine, Charlottesville, Virginia 22908-0736</aff><aff id="aff2" rid="aff7"><label>&#x02225;</label>Departments of Biochemistry</aff><aff id="aff6" rid="aff7"><label>&#x022a5;</label>Chemistry</aff><aff id="aff7">University of Wisconsin&#x02212;Madison, Madison, Wisconsin 53706</aff><aff id="aff3"><label>#</label>Physical Biosciences Division, Lawrence Berkeley National Laboratory, MS4R0230, Berkeley, California 94720</aff><aff id="aff4"><label>&#x025b3;</label>Physics Division, MS D454, Los Alamos National Laboratory, Los Alamos, New Mexico 87545</aff><aff id="aff5"><label>&#x025c7;</label>Biosciences Division, Midwest Center for Structural Genomics and Structural Biology Center, Argonne National Laboratory, 9700 South Cass Avenue, Argonne, Illinois 60439</aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>To whom correspondence should be addressed. R.T.R.: phone, <phone>(608) 262-8588</phone>; e-mail, <email>rtraines@wisc.edu</email>. Z.S.D.: phone, <phone>(434) 243-6842</phone>; e-mail, <email>zsd4n@virginia.edu</email>.</corresp><fn id="fn2"><label>&#x025cb;</label><p>Present address: Department of Molecular Neurochemistry, Medical University, 6/8 Mazowiecka St., 92-215 Lodz, Poland.</p></fn></author-notes><pub-date pub-type="epub"><day>04</day><month>08</month><year>2009</year></pub-date><pub-date pub-type="ppub"><day>15</day><month>09</month><year>2009</year></pub-date><volume>48</volume><issue>36</issue><fpage>8664</fpage><lpage>8671</lpage><history><date date-type="received"><day>13</day><month>03</month><year>2009</year></date><date date-type="rev-recd"><day>01</day><month>08</month><year>2009</year></date><date date-type="asap"><day>21</day><month>08</month><year>2009</year></date><date date-type="issue-pub"><day>15</day><month>09</month><year>2009</year></date><date date-type="just-accepted"><day>04</day><month>08</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 American Chemical Society</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>American Chemical Society</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://pubs.acs.org" license-type="open-access"><license-p>This is an open-access article distributed under the ACS AuthorChoice Terms &#x00026; Conditions. Any use of this article, must conform to the terms of that license which are available at <uri xlink:href="http://pubs.acs.org">http://pubs.acs.org</uri>.</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2009-00437z_0004" id="tgr1"/></p><p>The DUF1094 family contains over 100 bacterial proteins, all containing a conserved CXC motif, with unknown function. We solved the crystal structure of the <italic>Bacillus subtilis</italic> representative, the product of the <italic>yphP</italic> gene. The protein shows remarkable structural similarity to thioredoxins, with a canonical &#x003b1;&#x003b2;&#x003b1;&#x003b2;&#x003b1;&#x003b2;&#x003b2;&#x003b1; topology, despite low amino acid sequence identity to thioredoxin. The CXC motif is found in the loop immediately downstream of the first &#x003b2;-strand, in a location equivalent to the CXXC motif of thioredoxins, with the first Cys occupying a position equivalent to the first Cys in canonical thioredoxin. The experimentally determined reduction potential of YphP is <italic>E</italic>&#x000b0;&#x02032; = &#x02212;130 mV, significantly higher than that of thioredoxin and consistent with disulfide isomerase activity. Functional assays confirmed that the protein displays a level of isomerase activity that might be biologically significant. We propose a mechanism by which the members of this family catalyze isomerization using the CXC catalytic site.</p></abstract><funding-group><funding-statement><funding-source>National Institutes of Health, United States</funding-source></funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>bi900437z</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>bi-2009-00437z</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value>40.75</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group><fn id="fs1" fn-type="funding-statement"><label>&#x02020;</label><p>This study was supported by NIH NIGMS Grant U54 GM074946-01US (Z.S.D.), Grant GM044783 (R.T.R.), and Grant U54 GM074942 (A.J.). K.L.G. was supported by Chemistry&#x02212;Biology Interface Training Grant T32 BM008505 (NIH). The ALS is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231.</p></fn></fn-group></notes><notes><fn-group><fn id="ac1" fn-type="accession-codes"><label>&#x02021;</label><p>The atomic coordinates and structure factors have been deposited in the Protein Data Bank, <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.rcsb.org">www.rcsb.org</uri> (PDB ID code <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pdb" xlink:href="3FHK">3FHK</ext-link>).</p></fn></fn-group></notes></front><body><p>The <italic>Bacillus subtilis</italic><italic>yphP</italic> gene codes for a member of a superfamily of over 100 prokaryotic, highly conserved proteins (DUF1094), found predominantly in <italic>Firmicutes</italic> such as <italic>Staphylococcus</italic> and <italic>Bacillus.</italic> No function has been assigned to this family, and to date there is no structure described for any of its representatives. Tertiary structure prediction using 3DJury (<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref>) suggests that YphP has a core domain with high similarity to the canonical thioredoxin (Trx)<xref rid="fn3" ref-type="fn">1</xref> fold, as exemplified by the <italic>Trypanosoma brucei</italic> Trx (1r26) or <italic>Malassezia sympodialis</italic> Trx (2j23), even though amino acid sequence identity level is very low (&#x0223c;15%). This similarity raises the possibility that members of the DUF1094 proteins constitute a family of oxidoreductases with the ability to catalyze the formation, reduction, and/or isomerization of disulfide bonds. However, they lack the canonical CXXC sequence of the active site and instead contain a CGC motif, atypical of thioredoxins or related oxidoreductases.<fn id="fn3"><label>1</label><p>Abbreviations: Trx, thioredoxin; PDI, protein disulfide isomerase; TEV, tobacco etch virus; DTNB, 5,5&#x02032;-dithiobis(2-nitrobenzoic acid); EDTA, ethylenediaminetetraacetic acid; NADH, reduced nicotinamide adenine dinucleotide.</p></fn></p><p>The ubiquitous Trx superfamily includes proteins with a unique fold, in which the central, mixed &#x003b2;-sheet is sequestered between several short &#x003b1;-helices (<xref ref-type="bibr" rid="ref3">3</xref>). These oxidoreductases contain a fingerprint CXXC sequence (where X denotes any amino acid), in which the two cysteines alternate between the reduced and oxidized states, allowing them to participate in disulfide-exchange reactions. The location of this active site sequence is highly conserved, at the end of the canonical &#x003b2;2 strand and into the following &#x003b1;-helix, so that the N-terminal Cys is in an extended conformation, while the remaining three amino acids assume &#x003b1;-helical secondary structure. Interestingly, the sequence of the XX dipeptide varies among the superfamily members and is important for modulating the redox properties of the protein (<xref ref-type="bibr" rid="ref4">4</xref>). For example, in DsbA, which catalyzes the formation of disulfide bonds in proteins secreted into the periplasmic space of <italic>Escherichia coli</italic>, a CPHC motif results in the highest known reduction potential (<italic>E</italic>&#x000b0;&#x02032; = &#x02212;121 mV) matching the oxidizing environment of the periplasm (<xref ref-type="bibr" rid="ref5">5</xref>). In contrast, cytosolic thioredoxins contain a canonical CGPC motif with an <italic>E</italic>&#x000b0;&#x02032; value that is 160 mV lower, i.e., &#x02212;270 mV, which indicates a preference for an oxidized state and matches the reducing environment of the cytoplasm (<xref ref-type="bibr" rid="ref6">6</xref>). Glutaredoxins contain a CPYC motif and their reduction potentials vary depending on structural context, so that the <italic>E. coli</italic> glutaredoxins 1 and 3 have reduction potentials of &#x02212;233 and &#x02212;198 mV, respectively (<xref ref-type="bibr" rid="ref6">6</xref>). Finally, the protein disulfide isomerase (PDI) of the yeast endoplasmic reticulum has a CGHC sequence and a reduction potential of &#x02212;180 mV (<xref ref-type="bibr" rid="ref7">7</xref>).</p><p>In spite of this functional diversity, the general architecture of the active site motif is highly conserved, so that no member of the thioredoxin superfamily has been found with fewer or more than two intervening residues between the cysteines. Consequently, the functional importance of the number of the residues between the cysteines for the reduction potential has been studied in synthetic peptides (<xref ref-type="bibr" rid="ref8">8</xref>). These experiments revealed that for peptides C(X)<sub><italic>n</italic></sub>C, where <italic>n</italic> &#x02264; 5, those with a single intervening residue have the least stable disulfide. It has also been shown that a CGC-NH<sub>2</sub> tripeptide has a reduction potential of &#x02212;167 mV, close to that of PDI, and that it exhibits disulfide isomerization activity (<xref ref-type="bibr" rid="ref9">9</xref>). A CXC motif engineered into the active site of an <italic>E. coli</italic> thioredoxin by deleting the Pro residue from the CGPC active site showed likewise a destabilized disulfide with a reduction potential of &#x02265;&#x02212;200 mV. In its reduced form, this variant displayed disulfide isomerase activity that was 25-fold greater than that of the synthetic CGC peptide (<xref ref-type="bibr" rid="ref9">9</xref>).</p><p>Surprisingly, amino acid sequence alignments showed that YphP, and all other members of the DUF1094 family, contains a CGC motif, involving Cys53 and Cys55, in a location analogous to the active site of thioredoxin. To gain insight into the structure and function of the DUF1094 family, we determined the crystal structure of the <italic>B. subtilis</italic> YphP at 2.1 &#x000c5; resolution. The refined model confirmed that the protein is structurally closely related to the thioredoxin superfamily and that Cys53 occupies a site corresponding to the canonical N-terminal cysteine in the CXXC motif; Cys55 is located in place of the Pro in Trx. To better understand the function of YphP, we determined its reduction potential and analyzed its isomerase activity by using a continuous assay that measures the rate of isomerization of non-native to native disulfide bonds in tachyplesin I (<xref ref-type="bibr" rid="ref10">10</xref>). We then used two single site variants, C53A and C55A, to investigate the role of each of the two cysteine residues in the active site. Finally, we compared the activity of YphP to that of &#x00394;P34 thioredoxin in the fluorescence assay. The results confirm that YphP represents a new family of oxidoreductases that have a natural CXC motif within its active site. Both the reduction potential and functional assays are consistent with protein disulfide isomerase activity.</p><sec sec-type="materials|methods" id="sec1"><title>Materials and Methods</title><sec id="sec1.1"><title>Protein Production and Crystallization</title><p>The <italic>B. subtilis</italic> YphP (also denoted APC1446) was originally selected as one of the targets for high-throughput structure determination by the Midwest Center for Structural Genomics (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.mcsg.anl.gov">http://www.mcsg.anl.gov</uri>). The open reading frame was amplified from genomic DNA with a recombinant KOD HiFi DNA polymerase (Novagen) from <italic>Thermococcus kodakaraensis</italic> using conditions and reagents provided by the vendor (Novagen). The gene was cloned into a pMCSG7 vector (<xref ref-type="bibr" rid="ref11">11</xref>) using a modified ligation-independent cloning protocol (<xref ref-type="bibr" rid="ref12">12</xref>). This construct produced a fusion protein with an N-terminal His<sub>6</sub> tag and a recognition site for the tobacco etch virus (TEV) protease. Unfortunately, further progress was impeded by the recalcitrance of the protein to crystallization. To circumvent this problem, we used the entropy reduction approach (<xref ref-type="bibr" rid="ref13">13</xref>&#x02212;<xref ref-type="bibr" rid="ref15">15</xref>). We identified three clusters with high conformational entropy residues: cluster 1, E39, K40, E42; cluster 2, K113, E114; and cluster 3, Q100, E101. Variants were generated in which residues in these clusters were replaced with either Tyr or Ala.</p><p>Wild-type protein was expressed with high yield in <italic>E. coli</italic> BL21(DE3)RIPL. The protein was purified using standard methods and a combination of nickel affinity chromatography (Ni-NTA agarose column; Qiagen), followed by rTEV proteolysis to cleave the His tag, and gel filtration in the presence of reducing agents (1 mM DTT, 5 mM &#x003b2;-mercaptoethanol) to circumvent aggregation caused by intermolecular disulfide formation. The protein was concentrated to 8&#x02212;15 mg/mL. Variant proteins were purified in a similar manner.</p><p>A custom set of conditions (<xref ref-type="bibr" rid="ref16">16</xref>) was used for crystallization screening against a reservoir of precipitant and an alternative reservoir containing salt (<xref ref-type="bibr" rid="ref17">17</xref>). The cluster 1 Ala variant and cluster 3 Tyr variant yielded poorly reproducible crystals under a variety of conditions. In contrast, the cluster 3 Ala variant (i.e., Q100A, E101A) gave reproducible crystals in two different conditions: 3.2 M (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub> and 0.1 M citric acid buffer at pH 5.0 and 2.0 M (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>. Following optimization, the best crystals were obtained from 2.6 M (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub> and 0.1 M HEPES buffer at pH 7.6 with added 30% trimethylamine <italic>N</italic>-oxide; 5 mM &#x003b2;-mercaptoethanol in the reservoir was necessary for crystals to reach maximal dimensions.</p><p>To generate the selenomethionine- (SeMet-) labeled protein samples, the protein was expressed in <italic>E</italic>. <italic>coli</italic> B834 cells. Seed cultures of 20 mL were grown in Luria broth for 4 h at 37 &#x000b0;C. The seed cultures were spun down at 3000 rpm and used to inoculate autoinduction medium containing SeMet. The cultures were grown for 4.5 h at 37 &#x000b0;C, followed by &#x0223c;16 h at 20 &#x000b0;C and another 24 h at 10 &#x000b0;C. Harvested cultures yielded &#x0223c;35 g of wet mass/2 L. Protein was purified using the procedure described above and yielded more than 100 mg of pure SeMet-labeled protein. Protein was concentrated to &#x0223c;25 mg/mL in a buffer containing 25 mM NaCl and 25 mM Tris buffer at pH 8.0 and 1 mM DTT. The structure was determined from SeMet-labeled crystals grown from 2 M (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub> and 100 mM Tris buffer at pH 6.5 and 5% PEP (pentaerythritol propoxylate) 629.</p><p>All single- and multiple-site mutations were introduced using the QuikChange site-directed mutagenesis kit (Stratagene) and confirmed by direct DNA sequencing. The respective protein variants were purified as described above for the wild type.</p><p>&#x00394;P34 <italic>E. coli</italic> thioredoxin was produced and purified as we described previously (<xref ref-type="bibr" rid="ref9">9</xref>).</p></sec><sec id="sec1.2"><title>Crystallography</title><p>The crystals of the Q100A, E101A variant are tetragonal, <italic>P</italic>4<sub>1</sub>2<sub>1</sub>2, with unit cell dimensions <italic>a</italic> = <italic>b</italic> = 68.16 &#x000c5; and <italic>c</italic> = 302.02 &#x000c5;, and contain four molecules in the asymmetric unit. The crystals contain &#x0223c;55% solvent. For data collection, a crystal was frozen in mother liquor containing additional 20% glycerol. Data were collected at beamline 5.0.2 of the Advanced Light Source (ALS). The multiwavelength anomalous diffraction (MAD) data, used to solve the structure, were collected at three wavelengths: 0.9795 &#x000c5; (peak), 0.9796 &#x000c5; (inflection point), and 0.9393 &#x000c5; (high energy remote). The data extended to 2.3&#x02212;2.5 &#x000c5; with the merging <italic>R</italic> factors ranging between 11.9% and 13.6% (see Table <xref rid="tbl1" ref-type="table">1</xref>). Positions of selenium atoms were identified with SHELXD (<xref ref-type="bibr" rid="ref18">18</xref>). Crystallographic phasing was done with SOLVE (<xref ref-type="bibr" rid="ref19">19</xref>). Phases were improved by iterative model building and refinement in RESOLVE (<xref ref-type="bibr" rid="ref19">19</xref>) followed by ARP-WARP (<xref ref-type="bibr" rid="ref20">20</xref>) and manual rebuilding with O (<xref ref-type="bibr" rid="ref21">21</xref>) and COOT (<xref ref-type="bibr" rid="ref22">22</xref>). Refinement was carried out with REFMAC5 (<xref ref-type="bibr" rid="ref23">23</xref>) and with PHENIX (<xref ref-type="bibr" rid="ref24">24</xref>) using the TLS (translation/libration/screw) approximation of thermal motion (<xref ref-type="bibr" rid="ref25">25</xref>). Solvent accessibility of the Cys residues was calculated using the PISA server (<xref ref-type="bibr" rid="ref26">26</xref>).</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>Crystallographic Data</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="left"/><col align="left"/></colgroup><thead><tr><th style="border:none;" align="center">&#x000a0;</th><th style="border:none;" align="center">remote</th><th style="border:none;" align="center">edge</th><th style="border:none;" align="center">peak</th></tr></thead><tbody><tr><td colspan="4" style="border:none;" align="center">Data Collection Statistics</td></tr><tr><td style="border:none;" align="left">wavelength (&#x000c5;)</td><td style="border:none;" align="left">0.9393</td><td style="border:none;" align="left">0.9796</td><td style="border:none;" align="left">0.9795</td></tr><tr><td style="border:none;" align="left">resolution (&#x000c5;)</td><td style="border:none;" align="left">75.0&#x02212;2.30 (2.39&#x02212;2.30)<xref rid="t1fn1" ref-type="table-fn">a</xref></td><td style="border:none;" align="left">75.0&#x02212;2.50 (2.59&#x02212;2.50)</td><td style="border:none;" align="left">75.0&#x02212;2.30 (2.39&#x02212;2.30)</td></tr><tr><td style="border:none;" align="left">total reflections</td><td style="border:none;" align="left">148455</td><td style="border:none;" align="left">167160</td><td style="border:none;" align="left">203269</td></tr><tr><td style="border:none;" align="left">unique reflections</td><td style="border:none;" align="left">30085</td><td style="border:none;" align="left">25434</td><td style="border:none;" align="left">33433</td></tr><tr><td style="border:none;" align="left">redundancy</td><td style="border:none;" align="left">4.93</td><td style="border:none;" align="left">6.57</td><td style="border:none;" align="left">6.08</td></tr><tr><td style="border:none;" align="left">completeness (%)</td><td style="border:none;" align="left">90.2 (59.1)</td><td style="border:none;" align="left">94.3 (71.5)</td><td style="border:none;" align="left">97.2 (82.9)</td></tr><tr><td style="border:none;" align="left"><italic>R</italic><sub>merge</sub> (%)<xref rid="t1fn2" ref-type="table-fn">b</xref></td><td style="border:none;" align="left">13.6 (42.3)</td><td style="border:none;" align="left">12.4 (48.2)</td><td style="border:none;" align="left">11.9 (49.1)</td></tr><tr><td style="border:none;" align="left">average <italic>I</italic>/&#x003c3;(<italic>I</italic>)</td><td style="border:none;" align="left">17.4 (2.1)</td><td style="border:none;" align="left">19.3 (1.9)</td><td style="border:none;" align="left">19.7 (2.2)</td></tr></tbody></table><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/></colgroup><tbody><tr><td colspan="2" style="border:none;" align="center">Refinement Statistics</td></tr><tr><td style="border:none;" align="left">resolution (&#x000c5;)</td><td style="border:none;" align="left">75.0&#x02212;2.30 (2.37&#x02212;2.30)<xref rid="t1fn1" ref-type="table-fn">a</xref></td></tr><tr><td style="border:none;" align="left">reflections (working)</td><td style="border:none;" align="left">31840 (2461)</td></tr><tr><td style="border:none;" align="left">reflections (test)</td><td style="border:none;" align="left">1593 (126)</td></tr><tr><td style="border:none;" align="left"><italic>R</italic><sub>work</sub> (%)<xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">19.0 (31.7)</td></tr><tr><td style="border:none;" align="left"><italic>R</italic><sub>free</sub> (%)<xref rid="t1fn3" ref-type="table-fn">c</xref></td><td style="border:none;" align="left">24.6 (37.3)</td></tr><tr><td style="border:none;" align="left">no. of protein atoms</td><td style="border:none;" align="left">4484</td></tr><tr><td style="border:none;" align="left">no. of water oxygens</td><td style="border:none;" align="left">249</td></tr><tr><td style="border:none;" align="left">no. of water sulfate ions</td><td style="border:none;" align="left">12</td></tr><tr><td style="border:none;" align="left">average <italic>B</italic> factors (&#x000c5;<sup>2</sup>)<xref rid="t1fn4" ref-type="table-fn">d</xref></td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="padding-left: 2em;" align="left">main chain</td><td style="border:none;" align="left">50.7</td></tr><tr><td style="padding-left: 2em;" align="left">side chain</td><td style="border:none;" align="left">56.3</td></tr><tr><td style="padding-left: 2em;" align="left">waters</td><td style="border:none;" align="left">50.6</td></tr><tr><td style="border:none;" align="left">rms deviation from ideal geometry</td><td style="border:none;" align="left">&#x000a0;</td></tr><tr><td style="padding-left: 2em;" align="left">bonds (&#x000c5;)</td><td style="border:none;" align="left">0.006</td></tr><tr><td style="padding-left: 2em;" align="left">angles (deg)</td><td style="border:none;" align="left">1.02</td></tr><tr><td style="border:none;" align="left">Ramachandran plot: favored (%)</td><td style="border:none;" align="left">97.9</td></tr><tr><td style="border:none;" align="left">Ramachandran plot: outliers (%)</td><td style="border:none;" align="left">0.0</td></tr></tbody></table><table-wrap-foot><fn id="t1fn1"><label>a</label><p>The numbers in parentheses describe the relevant value for the highest resolution shell.</p></fn><fn id="t1fn2"><label>b</label><p><italic>R</italic><sub>merge</sub> = &#x02211;&#x02223;<italic>I</italic><sub><italic>i</italic></sub> &#x02212; &#x027e8;<italic>I</italic>&#x027e9;&#x02223;/&#x02211;<italic>I</italic>, where <italic>I</italic><sub><italic>i</italic></sub> is the intensity of the <italic>i</italic>th observation and &#x027e8;<italic>I</italic>&#x027e9; is the mean intensity of the reflections. The values are for unmerged Friedel pairs.</p></fn><fn id="t1fn3"><label>c</label><p><italic>R</italic> = &#x02211;&#x02223;&#x02223;<italic>F</italic><sub>o</sub>&#x02223; &#x02212; &#x02223;<italic>F</italic><sub>c</sub>&#x02223;&#x02223;/&#x02211;&#x02223;F<sub>o</sub>&#x02223;, crystallographic <italic>R</italic> factor, and <italic>R</italic><sub>free</sub> = &#x02211;&#x02223;&#x02223;<italic>F</italic><sub>o</sub>&#x02223; &#x02212; &#x02223;<italic>F</italic><sub>c</sub>&#x02223;&#x02223;/&#x02211;&#x02223;F<sub>o</sub>&#x02223;, where all reflections belong to a test set of randomly selected data; <italic>R</italic><sub>overall</sub> = crystallographic <italic>R</italic> factor calculated for all data after a final cycle of refinement.</p></fn><fn id="t1fn4"><label>d</label><p><italic>B</italic> factors were refined using TLS approximation (see Materials and Methods).</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec1.3"><title>Isomerase Activity</title><p>Assays of disulfide isomerase activity were performed with a synthetic fluorescent substrate as described previously (<xref ref-type="bibr" rid="ref10">10</xref>). The final concentration of enzyme was 1 &#x003bc;M. Kinetic parameters were determined by nonlinear least-squares regression analysis using eq <xref rid="eq1" ref-type="disp-formula">1</xref>:<disp-formula id="eq1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2009-00437z_m001" position="anchor"/></disp-formula></p></sec><sec id="sec1.4"><title>Disulfide Bond Reduction Potential</title><p>The reduction potential of the disulfide bond in YphP was determined from the thiol&#x02212;disulfide exchange equilibrium between YphP and glutathione. YphP (10 &#x003bc;M) was incubated in 50 mM sodium phosphate, pH 7.6, containing EDTA (1 mM) and various ratios of reduced/oxidized glutathione, <italic>E</italic>&#x000b0;&#x02032; = &#x02212;0.252 V (<xref ref-type="bibr" rid="ref27">27</xref>). The reaction mixture was blanketed with Ar(g), and the reaction was allowed to proceed for 60 min at 30 &#x000b0;C, after which it was quenched and YphP was precipitated by the addition of trichloroacetic acid to 10%. The precipitated protein was washed with acetone and resuspended in 100 mM sodium phosphate, pH 7.6, containing 5,5&#x02032;-dithiobis(2-nitrobenzoic acid) (DTNB; 0.10 mg/mL). The concentration of thiols was quantified by the ensuing absorbance at 412 nm. The amount of reduced YphP was compared to that of YphP that had been incubated with DTT (1 mM) to obtain the fraction of reduced YphP (<italic>f</italic> in eq <xref rid="eq2" ref-type="disp-formula">2</xref>). The standard reduction potential of YphP was calculated by nonlinear least-squares analysis of the data with the Nernst equation (eq <xref rid="eq2" ref-type="disp-formula">2</xref>):<disp-formula id="eq2"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2009-00437z_m002" position="anchor"/></disp-formula>where <italic>n</italic> is the number of electrons, <italic>F</italic> is the Faraday constant (96485 J V<sup>&#x02212;1</sup> mol<sup>&#x02212;1</sup>), <italic>R</italic> is the gas constant (8.314 J K<sup>&#x02212;1</sup> mol<sup>&#x02212;1</sup>), <italic>T</italic> is the temperature (here, 303 K), <italic>E</italic> is the reduction potential of the solution, and <italic>E</italic>&#x000b0; is the reduction potential of YphP.</p></sec></sec><sec id="sec2"><title>Results and Discussion</title><sec id="sec2.1"><title>Crystal Structure</title><p>The crystal structure was solved using the multiwavelength anomalous dispersion (MAD) method, and the atomic model was refined to an <italic>R</italic> factor of 19.4% (Table <xref rid="tbl1" ref-type="table">1</xref>). The final model contains 584 amino acid residues (from four independent protein molecules), 249 water molecules, and 12 SO<sub>4</sub><sup>2&#x02212;</sup> ions. Of the residues 93.4% are in the most favored regions of the Ramachandran plot with the remaining residues in additionally allowed regions. Three out of the four molecules show interpretable electron density for all 144 residues with an additional cloning artifact of three residues (SNA) on the N-terminus. The fourth molecule is slightly less well defined, and only residues 1&#x02212;143 were placed in the electron density. A number of electron density peaks in the solvent region were attributed to sulfate ions. Details of the data collection, refinement, and model quality statistics are listed in Table <xref rid="tbl1" ref-type="table">1</xref>.</p><p>The four molecules in the asymmetric unit are arranged into a dimer of dimers in which the major contacts are mediated by an N-terminal helix, unique to YphP and not found in a canonical thioredoxin fold (Figure <xref rid="fig1" ref-type="fig">1</xref>A). A comparison of the tertiary structure of YphP to other known structures using DALI (<xref ref-type="bibr" rid="ref28">28</xref>) shows that, with the exception of the N-terminal helix, the protein is very similar to a typical thioredoxin, with the highest similarity (<italic>Z</italic> score of 11.6) to the human thioredoxin (<xref ref-type="bibr" rid="ref29">29</xref>). The canonical &#x003b1;&#x003b2;&#x003b1;&#x003b2;&#x003b1;&#x003b2;&#x003b2;&#x003b1; topology is well conserved, although there are differences in the mutual disposition and lengths of the individual helices and loops (Figure <xref rid="fig1" ref-type="fig">1</xref>B). The tetrameric ensemble appears to constitute a crystallographic artifact, because gel filtration data (not shown) show that the protein is monomeric in solution.</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>(A) Packing of four crystallographically independent molecules of YphP. (B) A single molecule of YphP with the secondary structure elements identified (&#x003b1;-helices red and &#x003b2;-strands yellow) and the two Cys side chains of the CXC motif shown as spheres and labeled; the additional N-terminal &#x003b1;-helix unique to the DUF1094 family is shown in cyan. (C) Analogous view of the human thioredoxin (PDB code <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pdb" xlink:href="1AUC">1AUC</ext-link>) shown for comparison. The annotations used here for the &#x003b1;-helices and &#x003b2;-sheets follow the standard convention for thioredoxins (<xref ref-type="bibr" rid="ref45">45</xref>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2009-00437z_0005" id="gr1" position="float"/></fig><p>The four crystallographically independent molecules display a degree of conformational variability with respect to the N-terminal &#x003b1;-helix, suggesting that the latter is flexible with respect to the core of the molecule. This may account, at least in part, for the recalcitrance of the wild-type protein to crystallization. Several intermolecular contacts define the molecular packing. Importantly, three out of four YphP molecules in the asymmetric unit form crystal contacts directly via the low-entropy patches generated by the Q100A, E101A substitutions. This pattern suggests that an oligomeric ensemble might first form transiently in solution and then be incorporated into the crystal via surface patches introduced by mutagenesis. A similar mechanism is observed for other proteins crystallized by this approach (Z. S. Derewenda, unpublished).</p><p>The CXC motif (Figure <xref rid="fig2" ref-type="fig">2</xref>) is located within a loop following the first &#x003b2;-strand, as predicted by 3D-Jury (<xref ref-type="bibr" rid="ref1">1</xref>) based on the amino acid sequence. Cys53 is in an extended conformation (&#x003d5; = &#x0223c;&#x02212;70, &#x003c8; = &#x0223c;165; the dihedral angles are similar in all four molecules), and its position within the active site loop is analogous to the first Cys of the canonical CXXC motif. Residue Gly54 (&#x003d5; = &#x0223c;&#x02212;45, &#x003c8; = &#x0223c;&#x02212;40) is the first amino acid of the &#x003b1;1 helix, while Cys55 occupies the position of the second X (Pro in thioredoxin). Of the two cysteines, Cys53 is more solvent exposed (&#x0223c;42 &#x000c5;<sup>2</sup>) than Cys55 (&#x0223c;17 &#x000c5;<sup>2</sup>), although there is some variability among the four molecules, and there is evidence of static disorder of the side chain of Cys55. The distances between the two S<sup>&#x003b3;</sup> atoms in the four molecules range from 3.6 to 5.9 &#x000c5;, ruling out intramolecular disulfide bonds in the crystal structure; thus, the crystal structure represents the reduced form of the enzyme, as expected from the presence of reducing agents. The sulfhydryl of Cys53 is involved in two hydrogen bonds: with the hydroxyl O<sup>&#x003b3;</sup> of Ser51 and with N<sup>&#x003b7;1</sup> of Arg121 (Figure <xref rid="fig2" ref-type="fig">2</xref>), although specific distances vary depending on the side chain conformation. Both of these residues are completely conserved within the family, suggesting a functional role. Interactions of arginines with thiolates are known in other redox-regulated proteins. For example, in the hydroperoxide resistance protein Ohr, the active site cysteine Cys60, which is directly involved in peroxide reduction, accepts a hydrogen bond from N<sup>&#x003b7;1</sup> of Arg18 at 3.4 &#x000c5; (<xref ref-type="bibr" rid="ref30">30</xref>). In the <italic>B. subtilis</italic> chaperone Hsp33, the Zn<sup>2+</sup>-binding Cys235 is within 3.4 &#x000c5; of N<sup>&#x003b7;1</sup> of Arg86 (<xref ref-type="bibr" rid="ref31">31</xref>). By contrast, Cys55 has no similar interactions. These different environments suggest that the p<italic>K</italic><sub>a</sub> value of Cys53 is lower than that of Cys55 and that Cys53 could be the key nucleophile in the active site.</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Structure of the catalytic loop of YphP. The coordinates used in this diagram are those of chain D but are representative of all four chains in the structure.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2009-00437z_0006" id="gr2" position="float"/></fig><p>In spite of the obvious similarity of the CGC motifs in YphP and the &#x00394;P34 variant of Trx (<xref ref-type="bibr" rid="ref9">9</xref>), the active sites of these two proteins need not be structurally equivalent. In Trx, the deletion of Pro34 might cause a compensating rotation of the &#x003b1;-helix, although there is no X-ray structure available to prove this notion. Also, given the amphipathic character of this helix, it is difficult to see how a deletion of Pro34 could be accomplished without disturbing the protein&#x02019;s stability. In fact, the thermal stability of the &#x00394;P34 variant has been shown to be lower than that of the wild-type protein by &#x0223c;10 &#x000b0;C (<xref ref-type="bibr" rid="ref9">9</xref>). In YphP, Cys55 simply occupies the place of Pro34 in Trx, while the position immediately downstream is occupied by an Ala, thus avoiding the strain that might characterize the &#x00394;P34 Trx variant.</p></sec><sec id="sec2.2"><title>DUF1094 Family</title><p>Figure <xref rid="fig3" ref-type="fig">3</xref> shows an alignment of representative amino acid sequences of proteins in the DUF1094 family, as listed in the Pfam database (<xref ref-type="bibr" rid="ref32">32</xref>). This family comprises 102 sequences in 62 species. The majority (80 sequences) are found among the <italic>Firmicutes</italic>, mostly in the <italic>Bacillus</italic> and <italic>Staphylococcus</italic> genera. Interestingly, in these genera there are nearly always two homologous genes of this family in any species. The remaining sequences are in <italic>Acidobacteria</italic> and <italic>Bacterioidetes</italic>, and there is only a single gene in each species. The family shows a relatively high level of amino acid conservation with several completely conserved motifs in addition to the CGCA active site. Topologically, all of these conserved motifs are clustered primarily in loops around the active site, suggesting a possible role in substrate recognition. The atypical, N-terminal &#x003b1;-helix is the least conserved fragment in the DUF1094 family. We were unable to identify any homologues of these proteins in eukaryotic genomes.</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Sequence alignment of representative members of the DUF1094 family. Black triangles show the four residues that we identify as the catalytic amino acids (further details in the text). Semiconserved and fully conserved residues are indicated by darkening blue color. The secondary structure elements are shown below the alignment as cylinders (&#x003b1;-helices) and arrows (&#x003b2;-sheets).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2009-00437z_0007" id="gr3" position="float"/></fig></sec><sec id="sec2.3"><title>Activity Assays</title><p>The overall structural similarity of YphP to thioredoxins and the presence of the CGC motif in the putative active site suggest that the protein, as well as its homologues in the DUF1094 family, constitutes a family of oxidoreductases. To confirm this hypothesis, we carried out functional assays.</p><p>First, we determined the reduction potential, <italic>E</italic>&#x000b0;&#x02032;, of YphP to be &#x02212;130 &#x000b1; 5 mV (Figure <xref rid="fig4" ref-type="fig">4</xref>). As pointed out above, for the known oxidoreductases with CXXC motifs in their active sites, the reduction potentials range from &#x02212;270 mV in the <italic>E. coli</italic> thioredoxin (<xref ref-type="bibr" rid="ref6">6</xref>), a cytosolic reductant, to &#x02212;122 mV in DsbA, which catalyzes oxidation of proteins secreted into the periplasm (<xref ref-type="bibr" rid="ref5">5</xref>). The stability of the active site disulfide bond is tuned, in part, by the amino acid residues between the active site cysteines, i.e., the XX residues in the CXXC motif. The reduction potential of YphP was determined to be <italic>E</italic>&#x000b0;&#x02032; = &#x02212;130 &#x000b1; 5 mV, a notably high value, consistent with YphP being an isomerase/oxidase rather than a reductase. The only other protein containing a CXC motif within an intact protein, for which <italic>E</italic>&#x000b0;&#x02032; has been determined, is the &#x00394;P34 variant of Trx; in that case <italic>E</italic>&#x000b0;&#x02032; &#x02265;&#x02212;200 mV, at least 70 mV higher than in wild-type Trx (<xref ref-type="bibr" rid="ref9">9</xref>). It seems that decreasing the number of intervening residues between the cysteines from two (CXXC) to one (CXC) provides at least one mechanism to increase the reduction potential of a thiol&#x02212;disulfide oxidoreductase. It is noteworthy, however, that for a synthetic CysGlyCysNH<sub>2</sub> peptide the reduction potential <italic>E</italic>&#x000b0;&#x02032; = &#x02212;167 mV (<xref ref-type="bibr" rid="ref9">9</xref>). Thus, the structural scaffold of YphP is also responsible for a further increase of <italic>E</italic>&#x000b0;&#x02032; by about 40 mV.</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p>Reduction potential of YphP. The fraction of reduced YphP (<italic>f</italic>) is plotted as a function of the solution reduction potential, which was established at 30 &#x000b0;C by using reduced and oxidized glutathione. Values are the mean (&#x000b1;SE) from three experiments. The data were fitted to eq <xref rid="eq2" ref-type="disp-formula">2</xref> to give <italic>E</italic>&#x000b0;&#x02032; = &#x02212;130 &#x000b1; 5 mV.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2009-00437z_0001" id="gr4" position="float"/></fig><p>We also showed that YphP was able to catalyze the isomerization of non-native to native disulfide bonds using tachyplesin I peptide as a substrate, yielding a <italic>k</italic><sub>cat</sub>/<italic>K</italic><sub>M</sub> value of (4.7 &#x000b1; 0.03) &#x000d7; 10<sup>3</sup> M<sup>&#x02212;1</sup> s<sup>&#x02212;1</sup>. This activity is &#x0223c;3% that of protein disulfide isomerase (PDI) (<xref ref-type="bibr" rid="ref10">10</xref>) and 42% that of &#x00394;P34 thioredoxin (Table <xref rid="tbl2" ref-type="table">2</xref>). To investigate the roles of the cysteine thiols of YphP, we replaced each of the active site cysteine residues with alanine, thus generating single-site C53A and C55A variants. Unexpectedly, both of these variants catalyzed the isomerization of disulfide bonds in the scrambled tachyplesin substrate. The C53A and C55A variants had <italic>k</italic><sub>cat</sub>/<italic>K</italic><sub>M</sub> values of (2.6 &#x000b1; 0.2) &#x000d7; 10<sup>3</sup> and (3.3 &#x000b1; 0.1) &#x000d7; 10<sup>3</sup> M<sup>&#x02212;1</sup> s<sup>&#x02212;1</sup>, respectively, only slightly lower than that of the wild-type protein. Yet, when <italic>both</italic> active site cysteine residues were replaced with alanines, resulting in the C53A/C55A variant, isomerase activity was abolished completely (Table <xref rid="tbl2" ref-type="table">2</xref>).</p><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><title>Values of <italic>k</italic><sub>cat</sub>/<italic>K</italic><sub>M</sub> for Catalysis of Disulfide Bond Isomerization</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="char" char="&#x000b1;"/></colgroup><thead><tr><th style="border:none;" align="center">enzyme</th><th style="border:none;" align="center">variant</th><th style="border:none;" align="center" char="&#x000b1;"><italic>k</italic><sub>cat</sub>/<italic>K</italic><sub>M</sub> (10<sup>3</sup> M<sup>&#x02212;1</sup> s<sup>&#x02212;1</sup>)</th></tr></thead><tbody><tr><td style="border:none;" align="left">YphP</td><td style="border:none;" align="left">wild type</td><td style="border:none;" align="char" char="&#x000b1;">4.7&#x02009;&#x000b1;&#x02009;0.1</td></tr><tr><td style="border:none;" align="left">YphP</td><td style="border:none;" align="left">C53A</td><td style="border:none;" align="char" char="&#x000b1;">2.6&#x02009;&#x000b1;&#x02009;0.2</td></tr><tr><td style="border:none;" align="left">YphP</td><td style="border:none;" align="left">C55A</td><td style="border:none;" align="char" char="&#x000b1;">3.3&#x02009;&#x000b1;&#x02009;0.1</td></tr><tr><td style="border:none;" align="left">YphP</td><td style="border:none;" align="left">C53A/C55A</td><td style="border:none;" align="char" char="&#x000b1;">0.3&#x02009;&#x000b1;&#x02009;0.2</td></tr><tr><td style="border:none;" align="left">Trx</td><td style="border:none;" align="left">&#x00394;P34</td><td style="border:none;" align="char" char="&#x000b1;">11.2&#x02009;&#x000b1;&#x02009;0.8</td></tr><tr><td style="border:none;" align="left">PDI</td><td style="border:none;" align="left">wild type</td><td style="border:none;" align="char" char="&#x000b1;">170&#x02009;&#x000b1; 50<xref rid="t2fn1" ref-type="table-fn">a</xref></td></tr><tr><td style="border:none;" align="left">PDI</td><td style="border:none;" align="left">CGHA/CGHA</td><td style="border:none;" align="char" char="&#x000b1;">86&#x02009;&#x000b1;&#x02009;35<xref rid="t2fn1" ref-type="table-fn">a</xref></td></tr></tbody></table><table-wrap-foot><fn id="t2fn1"><label>a</label><p>Data from ref (<xref ref-type="bibr" rid="ref10">10</xref>).</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec2.4"><title>The Catalytic Mechanism</title><p>The canonical mechanism of disulfide bond isomerization by PDI involves an attack on the substrate disulfide bond by the thiolate of the N-terminal cysteine of the CXXC motif (<xref ref-type="bibr" rid="ref33">33</xref>&#x02212;<xref ref-type="bibr" rid="ref35">35</xref>). A mixed disulfide is formed between PDI and the substrate, enabling the thiol and disulfides of the substrate to react until native disulfide bonds are formed in the substrate, so that PDI is no longer tethered to it by a mixed disulfide. Replacing the N-terminal Cys in PDI with a Ser eliminates enzymatic activity (<xref ref-type="bibr" rid="ref36">36</xref>). In contrast, replacing the C-terminal Cys eliminates the ability of the enzyme to catalyze substrate reduction and oxidation but not isomerization (<xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref37">37</xref>). During the rearrangement of disulfides in the substrate protein, a stable mixed disulfide between PDI and the substrate could prevent the release of PDI. The C-terminal cysteine of PDI is thought to provide an &#x0201c;escape&#x0201d; mechanism in which a disulfide is formed within the active site of PDI to allow for substrate release (<xref ref-type="bibr" rid="ref8">8</xref>&#x02212;<xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref37">37</xref>). A similar role has been ascribed to the C-terminal cysteine residue of thioredoxin (<xref ref-type="bibr" rid="ref38">38</xref>).</p><p>The crystal structure of YphP suggests that the protein functions as a disulfide isomerase using a mechanism similar to that of protein disulfide isomerase (Figure <xref rid="fig5" ref-type="fig">5</xref>). In the reduced form, Cys53 is most likely the attacking nucleophile, activated by Arg121. When a stable intermolecular disulfide forms, an escape route is provided by Cys55 which, we suggest, also becomes activated by Arg121 swinging into a new position, so that an intramolecular disulfide can form. This putative mechanism involves a crucial role assigned to Arg121, which is absolutely conserved in the DUF1094 family (Figure <xref rid="fig3" ref-type="fig">3</xref>). We suggest that the escape route involves transient formation of a Cys53&#x02212;Cys55 disulfide, although we have not confirmed this experimentally.</p><fig id="fig5" position="float"><label>Figure 5</label><caption><p>Diagram of the proposed reaction mechanism catalyzed by YphP and its homologues.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2009-00437z_0002" id="gr5" position="float"/></fig><p>Oxidized CXC sequences, which are unusual 11-member ring structures, are extremely rare in nature. The only examples in the PDB of high-resolution structures containing such motifs are the thermophilic Ak.1 protease from <italic>B. subtilis</italic>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pdb" xlink:href="1DBI">1DBI</ext-link>(<xref ref-type="bibr" rid="ref39">39</xref>), the L40C variant of the NADH peroxidase, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pdb" xlink:href="1NHR">1NHR</ext-link>(<xref ref-type="bibr" rid="ref40">40</xref>), and Erv2p, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pdb" xlink:href="1JR">1JR8</ext-link>(<xref ref-type="bibr" rid="ref41">41</xref>) (Figure <xref rid="fig6" ref-type="fig">6</xref>). A similar disulfide is also reported in the <italic>Mengo encephalomyelitis</italic> virus coat protein (<xref ref-type="bibr" rid="ref42">42</xref>), although low resolution precludes detailed stereochemical analysis. Sep15 has a redox-active CX(C/U) motif, where &#x0201c;U&#x0201d; refers to selenocysteine and the use of C or U varies between organisms (<xref ref-type="bibr" rid="ref43">43</xref>). Finally, there is evidence that a CXC disulfide plays a functional role in the chaperone Hsp33 (<xref ref-type="bibr" rid="ref44">44</xref>), but no structure of the oxidized protein is available. In all three cases where high-resolution data are available, the torsion angles of the disulfide-containing ring suggest significant strain. It is interesting to note that the backbone conformations in the 11-member rings are different: in the Ak.1 protease and in Erv2P the residue in the X position is in the left-handed helical conformation, while in the NADH peroxidase variant a serine occupying the equivalent position is in the right-handed helical conformation, very similar to Gly in YphP (Figure <xref rid="fig6" ref-type="fig">6</xref>). Based on these structural comparisons, it appears that a disulfide bond in YphP is stereochemically possible, with a slight conformational adjustment to Cys55.</p><fig id="fig6" position="float"><label>Figure 6</label><caption><p>Structures of known oxidized CXC motifs and the reduced CXC motif of YphP; for details see text. The colors reflect atom type: yellow, carbon; blue, nitrogen; red, oxygen; green, sulfur.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="bi-2009-00437z_0003" id="gr6" position="float"/></fig><p>The observed activity of the two variants with only one of either of the active site cysteines is easily rationalized in view of the fact that the escape mechanism is not necessary for the enzyme to function in assays with peptides, as described elsewhere (<xref ref-type="bibr" rid="ref10">10</xref>). In the wild-type protein, Cys53 is likely to be the key nucleophile that attacks the substrate. It is more solvent exposed than Cys55, and the proximity of Arg121 makes its thiolate form more stable. However, in the absence of Cys53, e.g., in the C53A variant, Arg121 could easily swing toward Cys55, which is still sufficiently exposed to be reactive. This arrangement is different from that in <italic>Saccharomyces cerevisiae</italic> PDI, where the C-terminal Cys is buried and unable to catalyze isomerization in the absence of the N-terminal Cys. Thus, the C53A and C55A variants can both catalyze isomerization.</p></sec></sec><sec id="sec3"><title>Conclusion</title><p>The <italic>B. subtilis</italic> YphP is a member of an unusual oxidoreductase superfamily of enzymes (DUF1094) with a natural CXC motif within the active site and a tertiary fold closely reminiscent of the thioredoxins. The experimentally determined reduction potential, <italic>E</italic>&#x000b0;&#x02032;, is &#x02212;130 &#x000b1; 5 mV. Functional assays show that YphP has a level of disulfide isomerase activity that might be biologically significant with natural substrates. The enzymes in this family are highly conserved and occur primarily in the <italic>Staphylococcus</italic> and <italic>Bacillus</italic> species. All of these organisms contain canonical genes that encode thioredoxins, which are cellular reducing agents that have only been crystallized in an oxidized state. It is possible that, unlike thioredoxins, the DUF1094 enzymes are cellular oxidizing agents or <italic>in vivo</italic> catalysts of oxidative protein folding. Further biological studies will be needed to answer this question.</p></sec></body><back><ack><title>Acknowledgments</title><p>We thank Dr. Frank Collart (Argonne National Laboratory) for providing an overexpressing clone of the YphP protein and Natalya Olekhnovitch (University of Virginia) for excellent technical assistance and the preparation of the YphP variants. The authors thank the staff at the BL 5.0.2 managed by the Berkeley Center for Structural Biology (BCSB) at the Advanced Light Source (ALS) for technical support. The BCSB is supported in part by the National Institutes of Health, National Institute of General Medical Sciences.</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Ginalski</surname><given-names>K.</given-names></name>; <name><surname>Elofsson</surname><given-names>A.</given-names></name>; <name><surname>Fischer</surname><given-names>D.</given-names></name>; <name><surname>Rychlewski</surname><given-names>L.</given-names></name> (<year>2003</year>) <article-title>3D-Jury: a simple approach to improve protein structure predictions</article-title>. <source>Bioinformatics</source><volume>19</volume>, 1015&#x02013;1018.<pub-id pub-id-type="pmid">12761065</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>von Grotthuss</surname><given-names>M.</given-names></name>; <name><surname>Pas</surname><given-names>J.</given-names></name>; <name><surname>Wyrwicz</surname><given-names>L.</given-names></name>; <name><surname>Ginalski</surname><given-names>K.</given-names></name>; <name><surname>Rychlewski</surname><given-names>L.</given-names></name> (<year>2003</year>) <article-title>Application of 3D-Jury, GRDB, and Verify3D in fold recognition</article-title>. <source>Proteins</source><volume>53</volume>, Suppl. 6418&#x02013;423.<pub-id pub-id-type="pmid">14579330</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Pan</surname><given-names>J. L.</given-names></name>; <name><surname>Bardwell</surname><given-names>J. C.</given-names></name> (<year>2006</year>) <article-title>The origami of thioredoxin-like folds</article-title>. <source>Protein Sci.</source><volume>15</volume>, 2217&#x02013;2227.<pub-id pub-id-type="pmid">17008712</pub-id></mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Quan</surname><given-names>S.</given-names></name>; <name><surname>Schneider</surname><given-names>I.</given-names></name>; <name><surname>Pan</surname><given-names>J.</given-names></name>; <name><surname>Von Hacht</surname><given-names>A.</given-names></name>; <name><surname>Bardwell</surname><given-names>J. C.</given-names></name> (<year>2007</year>) <article-title>The CXXC motif is more than a redox rheostat</article-title>. <source>J. Biol. Chem.</source><volume>282</volume>, 28823&#x02013;28833.<pub-id pub-id-type="pmid">17675287</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Grauschopf</surname><given-names>U.</given-names></name>; <name><surname>Winther</surname><given-names>J. R.</given-names></name>; <name><surname>Korber</surname><given-names>P.</given-names></name>; <name><surname>Zander</surname><given-names>T.</given-names></name>; <name><surname>Dallinger</surname><given-names>P.</given-names></name>; <name><surname>Bardwell</surname><given-names>J. C.</given-names></name> (<year>1995</year>) <article-title>Why is DsbA such an oxidizing disulfide catalyst?</article-title>. <source>Cell</source><volume>83</volume>, 947&#x02013;955.<pub-id pub-id-type="pmid">8521518</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><name><surname>Aslund</surname><given-names>F.</given-names></name>; <name><surname>Berndt</surname><given-names>K. D.</given-names></name>; <name><surname>Holmgren</surname><given-names>A.</given-names></name> (<year>1997</year>) <article-title>Reduction potentials of glutaredoxins and other thiol-disulfide oxidoreductases of the thioredoxin superfamily determined by direct protein-protein redox equilibria</article-title>. <source>J. Biol. Chem.</source><volume>272</volume>, 30780&#x02013;30786.<pub-id pub-id-type="pmid">9388218</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Laboissi&#x000e8;re</surname><given-names>M. C.</given-names></name>; <name><surname>Sturley</surname><given-names>S. L.</given-names></name>; <name><surname>Raines</surname><given-names>R. T.</given-names></name> (<year>1995</year>) <article-title>The essential function of protein-disulfide isomerase is to unscramble non-native disulfide bonds</article-title>. <source>J. Biol. Chem.</source><volume>270</volume>, 28006&#x02013;28009.<pub-id pub-id-type="pmid">7499282</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Zhang</surname><given-names>R. M.</given-names></name>; <name><surname>Snyder</surname><given-names>G. H.</given-names></name> (<year>1989</year>) <article-title>Dependence of formation of small disulfide loops in two-cysteine peptides on the number and types of intervening amino acids</article-title>. <source>J. Biol. Chem.</source><volume>264</volume>, 18472&#x02013;18479.<pub-id pub-id-type="pmid">2808384</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Woycechowsky</surname><given-names>K. J.</given-names></name>; <name><surname>Raines</surname><given-names>R. T.</given-names></name> (<year>2003</year>) <article-title>The CXC motif: a functional mimic of protein disulfide isomerase</article-title>. <source>Biochemistry</source><volume>42</volume>, 5387&#x02013;5394.<pub-id pub-id-type="pmid">12731880</pub-id></mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Kersteen</surname><given-names>E. A.</given-names></name>; <name><surname>Barrows</surname><given-names>S. R.</given-names></name>; <name><surname>Raines</surname><given-names>R. T.</given-names></name> (<year>2005</year>) <article-title>Catalysis of protein disulfide bond isomerization in a homogeneous substrate</article-title>. <source>Biochemistry</source><volume>44</volume>, 12168&#x02013;12178.<pub-id pub-id-type="pmid">16142915</pub-id></mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Stols</surname><given-names>L.</given-names></name>; <name><surname>Gu</surname><given-names>M.</given-names></name>; <name><surname>Dieckman</surname><given-names>L.</given-names></name>; <name><surname>Raffen</surname><given-names>R.</given-names></name>; <name><surname>Collart</surname><given-names>F. R.</given-names></name>; <name><surname>Donnelley</surname><given-names>M. I.</given-names></name> (<year>2002</year>) <article-title>A new vector for high-throughput, ligation-independent cloning encoding a tobacco etch virus protease cleavage site</article-title>. <source>Protein Expression Purif.</source><volume>25</volume>, 1&#x02013;7.</mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Dieckman</surname><given-names>L.</given-names></name>; <name><surname>Gu</surname><given-names>M.</given-names></name>; <name><surname>Stols</surname><given-names>L.</given-names></name>; <name><surname>Donnelley</surname><given-names>M. I.</given-names></name>; <name><surname>Collart</surname><given-names>F. R.</given-names></name> (<year>2002</year>) <article-title>High throughput methods for gene cloning and expression</article-title>. <source>Protein Expression Purif.</source><volume>25</volume>, 8&#x02013;15.</mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal" id="cit13"><name><surname>Goldschmidt</surname><given-names>L.</given-names></name>; <name><surname>Cooper</surname><given-names>D. R.</given-names></name>; <name><surname>Derewenda</surname><given-names>Z. S.</given-names></name>; <name><surname>Eisenberg</surname><given-names>D.</given-names></name> (<year>2007</year>) <article-title>Toward rational protein crystallization: a Web server for the design of crystallizable protein variants</article-title>. <source>Protein Sci.</source><volume>16</volume>, 1569&#x02013;1576.<pub-id pub-id-type="pmid">17656576</pub-id></mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Derewenda</surname><given-names>Z. S.</given-names></name>; <name><surname>Vekilov</surname><given-names>P. G.</given-names></name> (<year>2006</year>) <article-title>Entropy and surface engineering in protein crystallization</article-title>. <source>Acta Crystallogr. </source><volume>D62</volume>, 116&#x02013;124.</mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Derewenda</surname><given-names>Z. S.</given-names></name> (<year>2004</year>) <article-title>Rational protein crystallization by mutational surface engineering</article-title>. <source>Structure</source><volume>12</volume>, 529&#x02013;535.<pub-id pub-id-type="pmid">15062076</pub-id></mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Cooper</surname><given-names>D. R.</given-names></name>; <name><surname>Boczek</surname><given-names>T.</given-names></name>; <name><surname>Grelewska</surname><given-names>K.</given-names></name>; <name><surname>Pinkowska</surname><given-names>M.</given-names></name>; <name><surname>Sikorska</surname><given-names>M.</given-names></name>; <name><surname>Zawadzki</surname><given-names>M.</given-names></name>; <name><surname>Derewenda</surname><given-names>Z.</given-names></name> (<year>2007</year>) <article-title>Protein crystallization by surface entropy reduction: optimization of the SER strategy</article-title>. <source>Acta Crystallogr.</source><volume>A63</volume>, 636&#x02013;645.</mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Newman</surname><given-names>J.</given-names></name> (<year>2005</year>) <article-title>Expanding screening space through the use of alternative reservoirs in vapor-diffusion experiments</article-title>. <source>Acta Crystallogr.</source><volume>D61</volume>, 490&#x02013;493.</mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Schneider</surname><given-names>T. R.</given-names></name>; <name><surname>Sheldrick</surname><given-names>G. M.</given-names></name> (<year>2002</year>) <article-title>Substructure solution with SHELXD</article-title>. <source>Acta Crystallogr.</source><volume>D58</volume>, 1772&#x02013;1779.</mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Terwilliger</surname><given-names>T. C.</given-names></name> (<year>2003</year>) <article-title>SOLVE and RESOLVE: automated structure solution and density modification</article-title>. <source>Methods Enzymol.</source><volume>374</volume>, 22&#x02013;37.<pub-id pub-id-type="pmid">14696367</pub-id></mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Morris</surname><given-names>R. J.</given-names></name>; <name><surname>Perrakis</surname><given-names>A.</given-names></name>; <name><surname>Lamzin</surname><given-names>V. S.</given-names></name> (<year>2003</year>) <article-title>ARP/wARP and automatic interpretation of protein electron density maps</article-title>. <source>Methods Enzymol.</source><volume>374</volume>, 229&#x02013;244.<pub-id pub-id-type="pmid">14696376</pub-id></mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><name><surname>Jones</surname><given-names>T. A.</given-names></name>; <name><surname>Zou</surname><given-names>J. Y.</given-names></name>; <name><surname>Cowan</surname><given-names>S. W.</given-names></name>; <name><surname>Kjeldgaard</surname><given-names>M.</given-names></name> (<year>1991</year>) <article-title>Improved methods for binding protein models in electron density maps and the location of errors in these models</article-title>. <source>Acta Crystallogr.</source><volume>A47</volume>, 110&#x02013;119.</mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Emsley</surname><given-names>P.</given-names></name>; <name><surname>Cowtan</surname><given-names>K.</given-names></name> (<year>2004</year>) <article-title>Coot: model-building tools for molecular graphics</article-title>. <source>Acta Crystallogr.</source><volume>D60</volume>, 2126&#x02013;2132.</mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Murshudov</surname><given-names>G. N.</given-names></name>; <name><surname>Vagin</surname><given-names>A. A.</given-names></name>; <name><surname>Dodson</surname><given-names>E. J.</given-names></name> (<year>1997</year>) <article-title>Refinement of macromolecular structures by the maximum-likelihood method</article-title>. <source>Acta Crystallogr.</source><volume>D53</volume>, 240&#x02013;255.</mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><name><surname>Zwart</surname><given-names>P. H.</given-names></name>; <name><surname>Afonine</surname><given-names>P. V.</given-names></name>; <name><surname>Grosse-Kunstleve</surname><given-names>R. W.</given-names></name>; <name><surname>Hung</surname><given-names>L. W.</given-names></name>; <name><surname>Ioerger</surname><given-names>T. R.</given-names></name>; <name><surname>McCoy</surname><given-names>A. J.</given-names></name>; <name><surname>McKee</surname><given-names>E.</given-names></name>; <name><surname>Moriarty</surname><given-names>N. W.</given-names></name>; <name><surname>Read</surname><given-names>R. J.</given-names></name>; <name><surname>Sacchettini</surname><given-names>J. C.</given-names></name>; <name><surname>Sauter</surname><given-names>N. K.</given-names></name>; <name><surname>Storoni</surname><given-names>L. C.</given-names></name>; <name><surname>Terwilliger</surname><given-names>T. C.</given-names></name>; <name><surname>Adams</surname><given-names>P. D.</given-names></name> (<year>2008</year>) <article-title>Automated structure solution with the PHENIX suite</article-title>. <source>Methods Mol. Biol.</source><volume>426</volume>, 419&#x02013;435.<pub-id pub-id-type="pmid">18542881</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal" id="cit25"><name><surname>Winn</surname><given-names>M. D.</given-names></name>; <name><surname>Isupov</surname><given-names>M. N.</given-names></name>; <name><surname>Murshudov</surname><given-names>G. N.</given-names></name> (<year>2001</year>) <article-title>Use of TLS parameters to model anisotropic displacements in macromolecular refinement</article-title>. <source>Acta Crystallogr.</source><volume>D57</volume>, 122&#x02013;133.</mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Krissinel</surname><given-names>E.</given-names></name>; <name><surname>Henrick</surname><given-names>K.</given-names></name> (<year>2007</year>) <article-title>Inference of macromolecular assemblies from crystalline state</article-title>. <source>J. Mol. Biol.</source><volume>372</volume>, 774&#x02013;797.<pub-id pub-id-type="pmid">17681537</pub-id></mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Lees</surname><given-names>W. J.</given-names></name>; <name><surname>Whitesides</surname><given-names>G. M.</given-names></name> (<year>1993</year>) <article-title>Equilibrium constants for thiol-disulfide interchange reactions: a coherent, corrected set</article-title>. <source>J. Org. Chem.</source><volume>58</volume>, 642&#x02013;647.</mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><person-group person-group-type="allauthors"><name><surname>Holm</surname><given-names>L.</given-names></name>, <name><surname>Kaariainen</surname><given-names>S.</given-names></name>, <name><surname>Wilton</surname><given-names>C.</given-names></name>, and <name><surname>Plewczynski</surname><given-names>D.</given-names></name></person-group> (2006) <article-title>Using Dali for structural comparison of proteins</article-title>, <source>Curr. Protoc. Bioinf., </source><comment>Chapter 5, Unit 5 5</comment>.</mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>Andersen</surname><given-names>J. F.</given-names></name>; <name><surname>Sanders</surname><given-names>D. A.</given-names></name>; <name><surname>Gasdaska</surname><given-names>J. R.</given-names></name>; <name><surname>Weichsel</surname><given-names>A.</given-names></name>; <name><surname>Powis</surname><given-names>G.</given-names></name>; <name><surname>Montfort</surname><given-names>W. R.</given-names></name> (<year>1997</year>) <article-title>Human thioredoxin homodimers: regulation by pH, role of aspartate 60, and crystal structure of the aspartate 60 &#x02192; asparagine mutant</article-title>. <source>Biochemistry</source><volume>36</volume>, 13979&#x02013;13988.<pub-id pub-id-type="pmid">9369469</pub-id></mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>Lesniak</surname><given-names>J.</given-names></name>; <name><surname>Barton</surname><given-names>W. A.</given-names></name>; <name><surname>Nikolov</surname><given-names>D. B.</given-names></name> (<year>2002</year>) <article-title>Structural and functional characterization of the <italic>Pseudomonas</italic> hydroperoxide resistance protein Ohr</article-title>. <source>EMBO J.</source><volume>21</volume>, 6649&#x02013;6659.<pub-id pub-id-type="pmid">12485986</pub-id></mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Janda</surname><given-names>I.</given-names></name>; <name><surname>Devedjiev</surname><given-names>Y.</given-names></name>; <name><surname>Derewenda</surname><given-names>U.</given-names></name>; <name><surname>Dauter</surname><given-names>Z.</given-names></name>; <name><surname>Bielnicki</surname><given-names>J.</given-names></name>; <name><surname>Cooper</surname><given-names>D. R.</given-names></name>; <name><surname>Graf</surname><given-names>P. C.</given-names></name>; <name><surname>Joachimiak</surname><given-names>A.</given-names></name>; <name><surname>Jakob</surname><given-names>U.</given-names></name>; <name><surname>Derewenda</surname><given-names>Z. S.</given-names></name> (<year>2004</year>) <article-title>The crystal structure of the reduced, Zn<sup>2+</sup>-bound form of the <italic>B. subtilis</italic> Hsp33 chaperone and its implications for the activation mechanism</article-title>. <source>Structure</source><volume>12</volume>, 1901&#x02013;1907.<pub-id pub-id-type="pmid">15458638</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>Finn</surname><given-names>R. D.</given-names></name>; <name><surname>Tate</surname><given-names>J.</given-names></name>; <name><surname>Mistry</surname><given-names>J.</given-names></name>; <name><surname>Coggill</surname><given-names>P. C.</given-names></name>; <name><surname>Sammut</surname><given-names>S. J.</given-names></name>; <name><surname>Hotz</surname><given-names>H. R.</given-names></name>; <name><surname>Ceric</surname><given-names>G.</given-names></name>; <name><surname>Forslund</surname><given-names>K.</given-names></name>; <name><surname>Eddy</surname><given-names>S. R.</given-names></name>; <name><surname>Sonnhammer</surname><given-names>E. L.</given-names></name>; <name><surname>Bateman</surname><given-names>A.</given-names></name> (<year>2008</year>) <article-title>The Pfam protein families database</article-title>. <source>Nucleic Acids Res.</source><volume>36</volume>, D281&#x02013;D288.<pub-id pub-id-type="pmid">18039703</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Woycechowsky</surname><given-names>K. J.</given-names></name>; <name><surname>Raines</surname><given-names>R. T.</given-names></name> (<year>2000</year>) <article-title>Native disulfide bond formation in proteins</article-title>. <source>Curr. Opin. Chem. Biol.</source><volume>4</volume>, 533&#x02013;539.<pub-id pub-id-type="pmid">11006541</pub-id></mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Wilkinson</surname><given-names>B.</given-names></name>; <name><surname>Gilbert</surname><given-names>H. F.</given-names></name> (<year>2004</year>) <article-title>Protein disulfide isomerase</article-title>. <source>Biochim. Biophys. Acta</source><volume>1699</volume>, 35&#x02013;44.<pub-id pub-id-type="pmid">15158710</pub-id></mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Kersteen</surname><given-names>E. A.</given-names></name>; <name><surname>Raines</surname><given-names>R. T.</given-names></name> (<year>2003</year>) <article-title>Catalysis of protein folding by protein disulfide isomerase and small-molecule mimics</article-title>. <source>Antioxid. Redox Signaling</source><volume>5</volume>, 413&#x02013;424.</mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Vuori</surname><given-names>K.</given-names></name>; <name><surname>Myllyl&#x000e4;</surname><given-names>R.</given-names></name>; <name><surname>Pihlajaniemi</surname><given-names>T.</given-names></name>; <name><surname>Kivirikko</surname><given-names>K. I.</given-names></name> (<year>1992</year>) <article-title>Expression and site-directed mutagenesis of human protein disulfide isomerase in <italic>Escherichia coli</italic></article-title>. <source>J. Biol. Chem.</source><volume>267</volume>, 7211&#x02013;7214.<pub-id pub-id-type="pmid">1559965</pub-id></mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Walker</surname><given-names>K. W.</given-names></name>; <name><surname>Lyles</surname><given-names>M. M.</given-names></name>; <name><surname>Gilbert</surname><given-names>H. F.</given-names></name> (<year>1996</year>) <article-title>Catalysis of oxidative protein folding by mutants of protein disulfide isomerase with a single active-site cysteine</article-title>. <source>Biochemistry</source><volume>35</volume>, 1972&#x02013;1980.<pub-id pub-id-type="pmid">8639681</pub-id></mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name><surname>Chivers</surname><given-names>P. T.</given-names></name>; <name><surname>Laboissi&#x000e8;re</surname><given-names>M. C. A.</given-names></name>; <name><surname>Raines</surname><given-names>R. T.</given-names></name> (<year>1996</year>) <article-title>The CXXC motif: imperatives for the formation of native disulfide bonds in the cell</article-title>. <source>EMBO J.</source><volume>16</volume>, 2659&#x02013;2667.<pub-id pub-id-type="pmid">8654363</pub-id></mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name><surname>Smith</surname><given-names>C. A.</given-names></name>; <name><surname>Toogood</surname><given-names>H. S.</given-names></name>; <name><surname>Baker</surname><given-names>H. M.</given-names></name>; <name><surname>Daniel</surname><given-names>R. M.</given-names></name>; <name><surname>Baker</surname><given-names>E. N.</given-names></name> (<year>1999</year>) <article-title>Calcium-mediated thermostability in the subtilisin superfamily: the crystal structure of <italic>Bacillus</italic> Ak.1 protease at 1.8 &#x000c5; resolution</article-title>. <source>J. Mol. Biol.</source><volume>294</volume>, 1027&#x02013;1040.<pub-id pub-id-type="pmid">10588904</pub-id></mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>Miller</surname><given-names>H.</given-names></name>; <name><surname>Mande</surname><given-names>S. S.</given-names></name>; <name><surname>Parsonage</surname><given-names>D.</given-names></name>; <name><surname>Sarfaty</surname><given-names>S. H.</given-names></name>; <name><surname>Hol</surname><given-names>W. G.</given-names></name>; <name><surname>Claiborne</surname><given-names>A.</given-names></name> (<year>1995</year>) <article-title>An L40C mutation converts the cysteine-sulfenic acid redox center in enterococcal NADH peroxidase to a disulfide</article-title>. <source>Biochemistry</source><volume>34</volume>, 5180&#x02013;5190.<pub-id pub-id-type="pmid">7711038</pub-id></mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name><surname>Gross</surname><given-names>E.</given-names></name>; <name><surname>Sevier</surname><given-names>C. S.</given-names></name>; <name><surname>Vala</surname><given-names>A.</given-names></name>; <name><surname>Kaiser</surname><given-names>C. A.</given-names></name>; <name><surname>Fass</surname><given-names>D.</given-names></name> (<year>2002</year>) <article-title>A new FAD-binding fold and intersubunit disulfide shuttle in the thiol oxidase Erv2p</article-title>. <source>Nat. Struct. Biol.</source><volume>9</volume>, 61&#x02013;67.<pub-id pub-id-type="pmid">11740506</pub-id></mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name><surname>Krishnaswamy</surname><given-names>S.</given-names></name>; <name><surname>Rossmann</surname><given-names>M. G.</given-names></name> (<year>1990</year>) <article-title>Structural refinement and analysis of Mengo virus</article-title>. <source>J. Mol. Biol.</source><volume>211</volume>, 803&#x02013;844.<pub-id pub-id-type="pmid">2156078</pub-id></mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name><surname>Ferguson</surname><given-names>A. D.</given-names></name>; <name><surname>Labunskyy</surname><given-names>V. M.</given-names></name>; <name><surname>Fomenko</surname><given-names>D. E.</given-names></name>; <name><surname>Arac</surname><given-names>D.</given-names></name>; <name><surname>Chelliah</surname><given-names>Y.</given-names></name>; <name><surname>Amezcua</surname><given-names>C. A.</given-names></name>; <name><surname>Rizo</surname><given-names>J.</given-names></name>; <name><surname>Gladyshev</surname><given-names>V. N.</given-names></name>; <name><surname>Deisenhofer</surname><given-names>J.</given-names></name> (<year>2006</year>) <article-title>NMR structures of the selenoproteins Sep15 and SelM reveal redox activity of a new thioredoxin-like family</article-title>. <source>J. Biol. Chem.</source><volume>281</volume>, 3536&#x02013;3543.<pub-id pub-id-type="pmid">16319061</pub-id></mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name><surname>Jakob</surname><given-names>U.</given-names></name>; <name><surname>Muse</surname><given-names>W.</given-names></name>; <name><surname>Eser</surname><given-names>M.</given-names></name>; <name><surname>Bardwell</surname><given-names>J. C.</given-names></name> (<year>1999</year>) <article-title>Chaperone activity with a redox switch</article-title>. <source>Cell</source><volume>96</volume>, 341&#x02013;352.<pub-id pub-id-type="pmid">10025400</pub-id></mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name><surname>Qi</surname><given-names>Y.</given-names></name>; <name><surname>Grishin</surname><given-names>N. V.</given-names></name> (<year>2005</year>) <article-title>Structural classification of thioredoxin-like proteins. <italic>Proteins</italic>:</article-title>. <source>Struct. Funct. Bioinf.</source><volume>58</volume>, 376&#x02013;388.</mixed-citation></ref></ref-list></back></article>